MedTrace Logo

4 Week Veterans Cannabidiol Intervention

NCT05850754 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-03

No results posted yet for this study

Summary

Cannabidiol (CBD), a non-psychoactive hemp derivative, is an attractive therapeutic agent, and is most supported by the scientific community as an antiepileptic. Additionally, CBD is also associated with claims related to improvements in overall health, pain, anxiety, depression, and sleep; however, the scientific evidence is lacking. The overarching goal of this investigation is to determine the effects of a 4-week CBD intervention on measures of overall health, pain, anxiety, depression, and sleep in a population of US veterans. Primary aims will explore the effects of 4 weeks of CBD on pain, anxiety, and depression. Secondary aims will determine whether 4 weeks of CBD will affect general measures of overall health and sleep.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Vantage Hemp CBD

Participants will consume 1 Vantage Hemp capsule, daily for 4 weeks.

DIETARY_SUPPLEMENT

Vantage Hemp Placebo Capsule

Vantage Hemp Placebo Capsule Intervention

Sponsors & Collaborators

  • University of Northern Colorado

    lead OTHER

Principal Investigators

  • Laura Stewart, PhD · University of Northern Colorado

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05850754 on ClinicalTrials.gov